FIRST ON FOX — The Food and Drug Administration is phasing out an animal testing requirement for antibody therapies and other drugs in favor of testing on materials that mimic human organs, the FDA ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

The US Food and Drug Administration (FDA) recently announced plans to phase out animal testing requirements, beginning with monoclonal antibodies and expanding to include other biological molecules ...

Advances in biomedical technology are reshaping how human disease is studied and treated, providing credible alternatives to animal testing Tools such as 3D-bioprinted tissues, organ-on-a-chip systems ...

A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Sara Dier and ...

AI and computational modeling are reducing reliance on animal testing by simulating human biology, improving drug safety and efficacy predictions. Regulatory bodies like the FDA and NIH are endorsing ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...

The Environmental Protection Agency is on a fast track toward eliminating animal testing, according to EPA Administrator Lee ...